CY1111318T1 - Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους - Google Patents
Διαδερματικη φαρμακοτεχνικη μορφη στεροειδουςInfo
- Publication number
- CY1111318T1 CY1111318T1 CY20101101106T CY101101106T CY1111318T1 CY 1111318 T1 CY1111318 T1 CY 1111318T1 CY 20101101106 T CY20101101106 T CY 20101101106T CY 101101106 T CY101101106 T CY 101101106T CY 1111318 T1 CY1111318 T1 CY 1111318T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sup
- group
- weight
- pharmaceutical form
- acrylate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ενώσεις τύπου (I) (όπου τα R1, R2, R3 και R4 είναι τα ίδια ή διαφορετικά το ένα από το άλλο και το καθένα αντιπροσωπεύει μια όξο ομάδα, υδρόξυ ομάδα, μερκάπτο ομάδα, άτομο υδρογόνου, άτομο αλογόνου, αλκόξυ ομάδα ή αρυλόξυ ομάδα και η στικτή γραμμή υποδεικνύει ότι μπορεί να υπάρχει απλός ή διπλός δεσμός μεταξύ ενός από τα αντίστοιχα ζεύγη ατόμων άνθρακα) και εστέρες αυτών, μπορεί να χορηγούνται με διαδερματική χορήγηση. Είναι ιδιαιτέρως αποτελεσματικές όταν εφαρμόζονται ως επίθεμα, κατά προτίμηση με συγκολλητικό που περιλαμβάνει συμπολυμερές από 40 έως 60% κατά βάρος ακρυλικό μεθοξυαιθυλαιθέρα, από 30 έως 40% κατά βάρος ακρυλικό λαουρύλ εστέρα ή μεθακρυλικό λαουρύλ εστέρα και από 10 έως 25% κατά βάρος πολικό μονομερές.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0409498.3A GB0409498D0 (en) | 2004-04-28 | 2004-04-28 | Transdermal steroid formulation |
EP05738733A EP1748779B1 (en) | 2004-04-28 | 2005-04-28 | Transdermal steroid formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111318T1 true CY1111318T1 (el) | 2015-08-05 |
Family
ID=32408193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101101106T CY1111318T1 (el) | 2004-04-28 | 2010-12-01 | Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους |
Country Status (25)
Country | Link |
---|---|
US (1) | US20070231373A1 (el) |
EP (1) | EP1748779B1 (el) |
JP (1) | JP4849478B2 (el) |
KR (1) | KR101139023B1 (el) |
CN (1) | CN1997375B (el) |
AT (1) | ATE480241T1 (el) |
AU (1) | AU2005237285B2 (el) |
CA (1) | CA2563830C (el) |
CY (1) | CY1111318T1 (el) |
DE (1) | DE602005023436D1 (el) |
DK (1) | DK1748779T3 (el) |
ES (1) | ES2352202T3 (el) |
GB (1) | GB0409498D0 (el) |
HK (1) | HK1096606A1 (el) |
HR (1) | HRP20100558T1 (el) |
IL (1) | IL178781A (el) |
NO (1) | NO337073B1 (el) |
NZ (1) | NZ550784A (el) |
PL (1) | PL1748779T3 (el) |
PT (1) | PT1748779E (el) |
RU (1) | RU2371183C2 (el) |
SI (1) | SI1748779T1 (el) |
TW (1) | TWI354557B (el) |
WO (1) | WO2005105104A1 (el) |
ZA (1) | ZA200608878B (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0523550D0 (en) | 2005-11-18 | 2005-12-28 | Hunter Fleming Ltd | Therapeutic uses of steroidal compounds |
MX2009005753A (es) * | 2006-11-30 | 2009-09-28 | Hunter Fleming Ltd | Modulacion de trayectorias metabolicas de prostaglandina/ciclooxig enasa. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE132751T1 (de) * | 1988-10-27 | 1996-01-15 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
EP0698612B1 (en) * | 1993-05-18 | 2001-07-25 | Ltt Institute Co., Ltd. | Osteogenesis promoter and osteoporosis remedy |
US5460820B1 (en) * | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
EP0827405A2 (en) * | 1995-05-15 | 1998-03-11 | Beth Israel Hospital | Use of dihydrotestosterone compounds for treating male sexual dysfunction |
US5783208A (en) * | 1996-07-19 | 1998-07-21 | Theratech, Inc. | Transdermal drug delivery matrix for coadministering estradiol and another steroid |
KR100215027B1 (ko) * | 1997-01-27 | 1999-08-16 | 성재갑 | 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형 |
US20010023261A1 (en) * | 1997-01-27 | 2001-09-20 | Lg Chemical Limited. | Novel composition for the transdermal administration of drugs |
DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
US20020012694A1 (en) * | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
US5869090A (en) * | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
GB2363984A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids |
GB2363983A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 7-hydroxyepiandrosterone |
ES2423899T3 (es) * | 2000-08-30 | 2013-09-25 | Unimed Pharmaceuticals, Llc | Método para aumentar las concentraciones de testosterona y esteroides relacionados en las mujeres |
FR2818148B1 (fr) * | 2000-12-15 | 2005-06-24 | Oreal | Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide |
US6510801B2 (en) * | 2001-06-01 | 2003-01-28 | Hong Sin Tan | Pallet for shrinkwrapped packaging of block rubber |
GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
EP1607104B1 (en) * | 2003-03-27 | 2015-12-09 | COSMED Pharmaceutical Co. Ltd. | Pressure-sensitive adhesive for percutaneous absorption, pressure-sensitive adhesive composition for percutaneous absorption, and medicinal preparation for percutaneous absorption |
-
2004
- 2004-04-28 GB GBGB0409498.3A patent/GB0409498D0/en not_active Ceased
- 2004-04-28 US US11/568,387 patent/US20070231373A1/en not_active Abandoned
-
2005
- 2005-04-27 TW TW094113457A patent/TWI354557B/zh not_active IP Right Cessation
- 2005-04-28 SI SI200531179T patent/SI1748779T1/sl unknown
- 2005-04-28 WO PCT/GB2005/001596 patent/WO2005105104A1/en active Application Filing
- 2005-04-28 AU AU2005237285A patent/AU2005237285B2/en not_active Ceased
- 2005-04-28 NZ NZ550784A patent/NZ550784A/en not_active IP Right Cessation
- 2005-04-28 AT AT05738733T patent/ATE480241T1/de active
- 2005-04-28 ES ES05738733T patent/ES2352202T3/es active Active
- 2005-04-28 PL PL05738733T patent/PL1748779T3/pl unknown
- 2005-04-28 RU RU2006141830/15A patent/RU2371183C2/ru not_active IP Right Cessation
- 2005-04-28 CA CA2563830A patent/CA2563830C/en not_active Expired - Fee Related
- 2005-04-28 DE DE602005023436T patent/DE602005023436D1/de active Active
- 2005-04-28 KR KR1020067024617A patent/KR101139023B1/ko not_active IP Right Cessation
- 2005-04-28 EP EP05738733A patent/EP1748779B1/en active Active
- 2005-04-28 DK DK05738733.4T patent/DK1748779T3/da active
- 2005-04-28 CN CN2005800175630A patent/CN1997375B/zh not_active Expired - Fee Related
- 2005-04-28 PT PT05738733T patent/PT1748779E/pt unknown
- 2005-04-28 JP JP2007510103A patent/JP4849478B2/ja not_active Expired - Fee Related
-
2006
- 2006-10-22 IL IL178781A patent/IL178781A/en not_active IP Right Cessation
- 2006-10-25 ZA ZA200608878A patent/ZA200608878B/xx unknown
- 2006-11-27 NO NO20065440A patent/NO337073B1/no not_active IP Right Cessation
-
2007
- 2007-04-10 HK HK07103709.9A patent/HK1096606A1/xx not_active IP Right Cessation
-
2010
- 2010-10-13 HR HR20100558T patent/HRP20100558T1/hr unknown
- 2010-12-01 CY CY20101101106T patent/CY1111318T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0818353A2 (pt) | Dispersões aquosas incluindo resina alquídica e polímero de adição tendo segmento(met)acrilato | |
EP2135908A3 (en) | Pressure-sensitive adhesive composition and pressure-sensitive adhesive sheet to be attached to metal surface | |
BR112014006188A2 (pt) | lentes hidrofóbicas intraoculares | |
ATE404250T1 (de) | Copolymere auf basis von tert.-butyl(meth)acrylat und deren verwendung in haarsprays | |
EP3064220A3 (en) | Compositions and methods for the treatment of infections and tumors | |
UY28744A1 (es) | Particulados | |
EP2135907A3 (en) | Pressure-sensitive adhesive composition, pressure-sensitive adhesive sheet, and method for producing the same | |
DE602006017961D1 (de) | Medizinische vorrichtungen mit legierungen | |
WO2012129362A3 (en) | Flame retarding adhesives | |
WO2009052411A3 (en) | Methods for treatment of thiol-containing compound deficient conditions | |
JP2012153772A5 (el) | ||
EP2135906A3 (en) | Pressure-sensitive adhesive composition and use thereof | |
HK1150619A1 (en) | Fluoropolymer emulsions | |
MXPA05007493A (es) | Nuevos copolimeros etilenicos, composiciones que los incluyen y procedimiento de tratamiento. | |
DE602005020996D1 (de) | Kaugummi und gummibasis enthaltend styrol-isopren-styrol-copolymere | |
WO2013095993A3 (en) | Water resistant personal care polymers | |
ATE508166T1 (de) | Copolymermischung | |
BRPI0513743A (pt) | medicamento em uma forma de multicamada | |
SE0401970D0 (sv) | Novel compounds | |
BR112013027484A2 (pt) | composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol | |
CY1111318T1 (el) | Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους | |
WO2012136818A3 (en) | Cosmetic composition comprising a cucurbic acid compound and a blend of acrylic polymers | |
ATE355348T1 (de) | Medizinische unvernetzte druckempfindliche klebstoffzubereitung, damit versehene medizinische selbstklebefolie und, verfahren zur herstellung von einer medizinischen unvernetzten druckempfindlichen klebstoffzubereitung | |
MX2015010449A (es) | Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos. | |
WO2008121461A3 (en) | Vaccine for activating helper function of cd8+ tcells |